Sun Pharm Industries Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDUSTRIES, and when can generic versions of SUN PHARM INDUSTRIES drugs launch?
SUN PHARM INDUSTRIES has one hundred and sixty-seven approved drugs.
There is one US patent protecting SUN PHARM INDUSTRIES drugs. There are two tentative approvals on SUN PHARM INDUSTRIES drugs.
There are twenty-two patent family members on SUN PHARM INDUSTRIES drugs in eighteen countries and one hundred and twenty-seven supplementary protection certificates in sixteen countries.
Summary for Sun Pharm Industries
| International Patents: | 22 |
| US Patents: | 1 |
| Tradenames: | 100 |
| Ingredients: | 97 |
| NDAs: | 167 |
Drugs and US Patents for Sun Pharm Industries
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 075515-004 | Oct 15, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | CAPSULE;ORAL | 089488-001 | Jan 2, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | TOLAZAMIDE | tolazamide | TABLET;ORAL | 071357-001 | Jul 16, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | NITROFURANTOIN | nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 201722-003 | Feb 16, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Industries | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 089590-001 | Oct 19, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Sun Pharm Industries | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 076038-002 | Feb 21, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm Industries
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| Sun Pharm Industries | BACTRIM DS | sulfamethoxazole; trimethoprim | TABLET;ORAL | 017377-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| Sun Pharm Industries | BACTRIM PEDIATRIC | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-002 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Sun Pharm Industries Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| India | 4160DEN2015 | ⤷ Try a Trial |
| Malaysia | 179354 | ⤷ Try a Trial |
| Ukraine | 115073 | ⤷ Try a Trial |
| Eurasian Patent Organization | 201590730 | ⤷ Try a Trial |
| Mexico | 2015004863 | ⤷ Try a Trial |
| European Patent Office | 2919753 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Industries Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0733366 | SPC/GB98/031 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 2-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL) BIPHENYL-4-YL)-METHYL)-5-(HYDROXYMETHYL)IMIDAZOLE (LOSARTAN),OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT( LOSARTAN POTASSIUM) AND HYDROCHLOROTHIAZIDE,; REGISTERED: FR 338520.7 19950215; FR 558453.7 19950215; UK 00025/0338 19960412 |
| 1532149 | 92128 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3, 7-DIHYDROPURIN-2, 6-DION, LES ENANTIOMERES ET LEURS SELS, EN PARTICULIER LA LINAGLIPTINE COMBINEE AVEC DU CHLORHYDRATE DE METFORMINE. LINAGLIPTINE |
| 1506211 | 122014000070 | Germany | ⤷ Try a Trial | PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, WIE DURCH DAS GRUNDPATENT GESCHUETZT; REGISTRATION NO/DATE: EU/1/13/900 20140116 |
| 1261586 | 15/2012 | Austria | ⤷ Try a Trial | PRODUCT NAME: KOMBINATIONSPRODUKT VON SAXAGLIPTIN UND METFORMIN UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON, BEINHALTEND DIE HYDROCHLORIDSALZE VON SAXAGLIPTIN UND METFORMIN; REGISTRATION NO/DATE: EU/1/11/731/001-EU/1/11/731/012 20111124 |
| 1261586 | 12C0028 | France | ⤷ Try a Trial | PRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124 |
| 0503785 | CA 2011 00026 | Denmark | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
